
Nucleon Research Private Limited
About Nucleon Research Private Limited
Data last updated:
Nucleon Research Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the hardware consulting segment of the professional services sector. It was incorporated on 12 May 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U72100MH2023PTC402795. Its GSTIN is 27AAICN8760D1Z8 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Anushka Vilas Salvi and Ananya Banerjee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.1 Lakh. For the same year it recorded a net loss of ₹66.14 Lakh (net margin -253.4%) and EBITDA of -₹65.9 Lakh (EBITDA margin -252.5%).
Company details
Contact details
Nucleon Research Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressHi – Life Premises Office, No 22 2nd Floor P M Road, Mumbai, Maharashtra, India – 400054
- IndustryProfessional Services, Hardware Consulting
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nucleon Research Private Limited
FY 2025 filings availableNucleon Research Private Limited reported revenue of ₹26.1 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹65.9 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹66.14 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -252.5% | |
| Net Profit Margin | -253.4% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Nucleon Research Private Limited, buy the company report.
Board of directors of Nucleon Research Private Limited
Nucleon Research has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anushka Vilas Salvi Also directs: Nucleon Therapeutics LLP | Director | 12 May 2023 | 3 Years 5 Months | Current |
| Ananya Banerjee Also directs: Spar Smart Food LLP | Director | 12 May 2023 | 3 Years 5 Months | Current |
| Robin Banerjee | Director | 07 Aug 2023 | 3 Years 2 Months | Current |
Peer comparison
Nucleon Research Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indya Clinical Research Private Limited | ₹26.49 Lakh (FY 2025) | -75.0% | Bangalore, Karnataka, India | |||
| Synthetic Research Pharma Laboratories Private Limited | ₹26.32 Lakh (FY 2025) | 148.0% | Hyderabad, Telangana, India | |||
| Poullac Pharmaceuticals Private Limited | ₹26.25 Lakh (FY 2025) | -77.0% | Saharanpur, Uttar Pradesh, India | |||
| Ils Foundation | ₹26.15 Lakh (FY 2025) | 56.0% | New Delhi, Delhi, India | |||
| Natural Elements Foundation | ₹26.14 Lakh (FY 2025) | 27.0% | Gurgaon, Haryana, India | |||
| Nucleon Research Private Limitedthis company | ₹26.1 Lakh (FY 2025) | -₹66.14 Lakh | -253.4% | Mumbai, Maharashtra, India | ||
| Crmo Pharmatech Private Limited | ₹24.57 Lakh (FY 2025) | -28.0% | Gandhinagar, Gujarat, India | |||
| Huda Medi Research Private Limited | ₹24.43 Lakh (FY 2025) | 132.0% | Pune, Maharashtra, India | |||
| Ileads Therapeuircs Private Limited | ₹24.42 Lakh (FY 2024) | -2.0% | Hyderabad, Telangana, India | |||
| Medanta Duke Research Institute Private Limited | ₹24 Lakh (FY 2019) | 0.0% | New Delhi, Delhi, India | |||
| Refsyn Biosciences Private Limited | ₹23.72 Lakh (FY 2025) | 30.0% | Puducherry, India |
To see the full peer comparison of Nucleon Research Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nucleon Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nucleon Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nucleon Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICN8760D1Z8 | Maharashtra | Active | 18 Sep 2023 |
To see the full GST registrations and return filing status of Nucleon Research Private Limited, buy the company report.
Recent activity
Nucleon Research Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Robin Banerjee ceased to be Additional Director on 14 Mar 2025.
Frequently asked questions
Nucleon Research is an active private limited company based in Mumbai, Maharashtra, India. The company works in hardware consulting, within the professional services industry. It was incorporated on 12 May 2023 (3+ years old) and is registered under CIN U72100MH2023PTC402795.
Nucleon Research has 3 current directors:
- Anushka Vilas Salvi - Director
- Ananya Banerjee - Director
- Robin Banerjee - Director
The latest financial statements of Nucleon Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Nucleon Research is 27AAICN8760D1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of Nucleon Research is U72100MH2023PTC402795. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nucleon Research was incorporated on 12 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Nucleon Research by revenue are Indya Clinical Research Private Limited, Synthetic Research Pharma Laboratories Private Limited, Poullac Pharmaceuticals Private Limited, Ils Foundation, Natural Elements Foundation and 5 more, all in the Pharma industry (Contract Research).
Robin Banerjee ceased to be Additional Director on 14 Mar 2025. Robin Banerjee was appointed as Director on 07 Aug 2023. Ananya Banerjee was appointed as Director on 12 May 2023. Nucleon Research has 4 board changes on record in total.
The registered office of Nucleon Research is at Hi – Life Premises Office, No 22 2nd Floor P M Road, Mumbai, Maharashtra, India – 400054.
Nucleon Research operates in the professional services industry, in the hardware consulting segment.
Nucleon Research can be reached at its registered office: Hi – Life Premises Office, No 22 2nd Floor P M Road, Mumbai, Maharashtra, India – 400054.